SCHEMBL26580970

SCHEMBL26580970

Cc1nc(CN2CCC(O)C2)nc(C)c1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CD274 Q9NZQ7 8/20 0.43
PDCD1LG2 Q9BQ51 3/20 0.43
PDCD1 Q15116 5/20 0.40
SYK P43405 3/20 0.38
ALDH1A1 P00352 3/20 0.37
PDE2A O00408 1/20 0.36
PDE5A O76074 1/20 0.36
PDE11A Q9HCR9 1/20 0.36
PDE10A Q9Y233 1/20 0.36
CYP3A4 P08684 1/20 0.35
JAK3 P52333 1/20 0.35
TSHR P16473 1/20 0.35
KDM4E B2RXH2 1/20 0.35
POLB P06746 1/20 0.35
HPGD P15428 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
GAA P10253 1/20 0.35
XBP1 P17861 1/20 0.35
MAPK1 P28482 1/20 0.35
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23809138 0.84 ALDH1A1 (0.40) CD274PDCD1LG2PDCD1SYKALDH1A1
SCHEMBL26038021 0.84 CD274 (0.38) CD274PDCD1LG2PDCD1SYKALDH1A1
SCHEMBL26043540 0.72 LMNA (0.49) ALDH1A1KDM4EHPGDGAAMAPK1
SCHEMBL31662619 0.72 ALDH1A1 (0.57) ALDH1A1PDE2APDE10ATSHRKDM4E
SCHEMBL31663310 0.70 MAPT (0.43) ALDH1A1PDE2APDE10AHPGDHTT
SCHEMBL21130555 0.70 PDE10A (0.48) CD274PDCD1LG2PDCD1SYKALDH1A1
SCHEMBL23863511 0.70 PDE10A (0.48) CD274PDCD1LG2PDCD1SYKALDH1A1
SCHEMBL26032241 0.69 GAA (0.44) ALDH1A1KDM4EHPGDSMN1; SMN2GAA
SCHEMBL19903801 0.69 CD274 (0.46) CD274PDCD1LG2PDCD1SYKALDH1A1
SCHEMBL30384759 0.69 CD274 (0.46) CD274PDCD1LG2PDCD1SYKALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230330099-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS VANDERBILT UNIVERSITY 2023-10-19 US disclosed
US-20230330099-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS VANDERBILT UNIVERSITY 2023-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230330099-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS MCL1, BCL2L1, BCL9 CD274 1983/4885PDCD1LG2 433/4885PDCD1 201/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.